Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Oakland Men's Health Disparities Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03481270
Recruitment Status : Completed
First Posted : March 29, 2018
Results First Posted : October 25, 2019
Last Update Posted : October 25, 2019
Sponsor:
Information provided by (Responsible Party):
Marcella Alsan, Stanford University

Brief Summary:
Reducing racial disparities in health outcomes is a major policy concern in the United States. Although there has been recent progress to close the gap, black men continue to experience earlier morbidity and mortality from preventable and manageable medical conditions, and live on average 4.2 years less than their white male peers. An oft-prescribed solution to close this stubborn gap is to increase the diversity of the healthcare workforce. Another common policy tool to increase take-up of preventative healthcare services is financial incentives. In this randomized evaluation, we will estimate the effects of financial incentives and a racially concordant physician on the uptake of preventive health services in Oakland, California.

Condition or disease Intervention/treatment Phase
Behavior Cardiovascular Risk Factor Influenza Behavioral: Concordant Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 1374 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: RCT
Masking: Double (Participant, Care Provider)
Primary Purpose: Other
Official Title: The Oakland Men's Health Disparities Study
Actual Study Start Date : October 14, 2017
Actual Primary Completion Date : March 3, 2018
Actual Study Completion Date : March 3, 2018

Arm Intervention/treatment
Placebo Comparator: Discordant
Does not receive the concordant provider.
Behavioral: Concordant
We will be randomizing across providers - we are particularly interested in racial concordance.

Experimental: Concordant
The intervention is that the subject receives the concordant provider.
Behavioral: Concordant
We will be randomizing across providers - we are particularly interested in racial concordance.




Primary Outcome Measures :
  1. Average Take-up of Preventive Services (Post-consultation) [ Time Frame: 1 day ]
    Take-up of preventative services was scored as either zero (did not utilize any post-consultation services) or 1 (utilized at least 1 post-consultation service). Four non-incentivized post-consultation preventive services were offered (for BMI, blood pressure, cholesterol, and/or diabetes); the subject had the opportunity to select service(s) after meeting with their assigned doctor.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • African American male adults

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03481270


Locations
Layout table for location information
United States, California
Barbershops / Fleamarkets
Oakland, California, United States, 94577
Sponsors and Collaborators
Stanford University
  Study Documents (Full-Text)

Documents provided by Marcella Alsan, Stanford University:
Layout table for additonal information
Responsible Party: Marcella Alsan, Assistant Professor, Stanford University
ClinicalTrials.gov Identifier: NCT03481270    
Other Study ID Numbers: 36255
First Posted: March 29, 2018    Key Record Dates
Results First Posted: October 25, 2019
Last Update Posted: October 25, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No